Ribosomal protein L23a pseudogene 16 (RPL23AP16)

Ribosomal protein L23a pseudogene 16 (RPL23AP16) is a processed pseudogene related to the functional ribosomal protein gene RPL23A. Pseudogenes like RPL23AP16 do not encode functional proteins and generally lack regulatory or coding function, although some ribosomal protein pseudogenes may be transcribed or have regulatory potential in rare contexts. There is no evidence in current gene or protein databases to suggest that RPL23AP16 encodes an active protein or plays a direct role in cellular pathways, disease, or pharmacology. It is not considered a therapeutic target or a biomarker. "RPL23AP16" is not a true functional protein, receptor, enzyme, or therapeutic target but a pseudogene. By biomedical convention, only genes that produce functional products (such as proteins or RNA with regulatory/structural roles) are considered valid targets. If you are seeking information on the functional protein, refer to 60S ribosomal protein L23a (RPL23A), which is involved in ribosome function and can influence cell growth and immune responses, but note that the pseudogene itself (RPL23AP16) does not share these properties. Pseudogenes are fragments or non-functional copies of genes that have lost their protein-coding or regulatory potential due to evolutionary mutations. There are more than 100 RPL23A pseudogenes in the human genome, and while a few have been studied for possible regulatory or disease roles (such as RPL23AP53 in melanoma), RPL23AP16 has no known biological or clinical relevance according to current sources. Summary: RPL23AP16 is a ribosomal protein pseudogene and should not be considered a therapeutic or biological target in its own right. For information on functional pathways or targeting, focus on the parent gene RPL23A (ribosomal protein L23a).

Other names

RPL23A_4_145RPL23AP16